MacroGenics Inc (MGNX):企業の財務・戦略的SWOT分析

◆英語タイトル:MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH135626FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MacroGenics Inc (MGNX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MacroGenics Inc (MacroGenics) is a biopharmaceutical company which focuses on the development and delivery of novel antibody-based therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders. Its pipeline includes product candidates for the treatment of solid tumors, breast and gastroesophageal cancers, type 1 diabetes, HIV, DART product candidates for the treatment of acute myeloid leukemia and myelodysplastic syndrome; and b-cell malignancies. The company’s product candidates are based on proprietary technology platforms, namely, Cancer Stem Cell Platform, Dual-Affinity Re-Targeting (or DART) and TRIDENT Platform and Fc Optimization Platform. It works in collaboration with major pharmaceutical and biotechnology companies to leverage its technology platforms and protein engineering capabilities to develop product candidates. MacroGenics is headquartered in Rockville, Maryland, the US.

MacroGenics Inc Key Recent Developments

Feb 25,2021: MacroGenics provides update on corporate progress and 2020 financial results
Feb 18,2021: MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call
Feb 11,2021: MacroGenics Names Federica O’Brien to its Board of Directors
Nov 04,2020: MacroGenics provides update on corporate progress and third quarter 2020 financial results
Jul 30,2020: MacroGenics provides update on corporate progress and second quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MacroGenics Inc – Key Facts
MacroGenics Inc – Key Employees
MacroGenics Inc – Key Employee Biographies
MacroGenics Inc – Major Products and Services
MacroGenics Inc – History
MacroGenics Inc – Company Statement
MacroGenics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
MacroGenics Inc – Business Description
Other Break-up: Revenue from Collaborative and Other Agreements
Performance
Other Break-up: Revenue from Government Agreements
Performance
MacroGenics Inc – Corporate Strategy
MacroGenics Inc – SWOT Analysis
SWOT Analysis – Overview
MacroGenics Inc – Strengths
MacroGenics Inc – Weaknesses
MacroGenics Inc – Opportunities
MacroGenics Inc – Threats
MacroGenics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MacroGenics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 25, 2021: MacroGenics provides update on corporate progress and 2020 financial results
Feb 18, 2021: MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call
Feb 11, 2021: MacroGenics Names Federica O’Brien to its Board of Directors
Nov 04, 2020: MacroGenics provides update on corporate progress and third quarter 2020 financial results
Jul 30, 2020: MacroGenics provides update on corporate progress and second quarter 2020 financial results
Jun 16, 2020: MacroGenics appoints Dr. Stephen Eck As Chief Medical Officer
May 05, 2020: MacroGenics provides update on corporate progress and first quarter 2020 financial results
Mar 04, 2020: MacroGenics announces Departure of Chief Medical Officer
Feb 25, 2020: MacroGenics provides update on corporate progress and 2019 financial results
Jan 09, 2020: MacroGenics outlines corporate priorities for 2020
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
MacroGenics Inc, Key Facts
MacroGenics Inc, Key Employees
MacroGenics Inc, Key Employee Biographies
MacroGenics Inc, Major Products and Services
MacroGenics Inc, History
MacroGenics Inc, Other Locations
MacroGenics Inc, Key Competitors
MacroGenics Inc, Ratios based on current share price
MacroGenics Inc, Annual Ratios
MacroGenics Inc, Annual Ratios (Cont...1)
MacroGenics Inc, Interim Ratios
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MacroGenics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MacroGenics Inc (MGNX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Public Financial Holdings Limited (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Limited (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • EBS Technologies GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary EBS Technologies GmbH (EBS) is a medical device company that develops stimulation system for visual field effect. The company offers Eyetronic Therapy, which has been developed for patients suffering from a progressive visual field loss due to glaucoma and other diseases of the optic nerve. …
  • Fuji Electric Co Ltd (6504):企業の財務・戦略的SWOT分析
    Fuji Electric Co Ltd (6504) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Anika Therapeutics Inc (ANIK):企業の財務・戦略的SWOT分析
    Anika Therapeutics Inc (ANIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • The Scotts Miracle-Gro Company (SMG):企業の財務・戦略的SWOT分析
    The Scotts Miracle-Gro Company (SMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Guizhou Space Appliance Co., Ltd.:企業の戦略・SWOT・財務情報
    Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Yamaha Corporation (7951):企業の財務・戦略的SWOT分析
    Yamaha Corporation (7951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mercer International Inc (MERC):企業の財務・戦略的SWOT分析
    Mercer International Inc (MERC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Korea Western Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea Western Power Co., Ltd. (KOWEPO), a subsidiary of Korea Electric Power Corporation (KEPCO), develops electricity resources, and generates and supplies electricity. The company’s power generation portfolio includes Taen, Pyeongtaek, Seoincheon, and Gunsan power complexes consisting of t …
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Daiwa Securities Group Inc:企業の戦略・SWOT・財務分析
    Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report Summary Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Pan-Provincial Vaccine Enterprise Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pan-Provincial Vaccine Enterprise Inc (PREVENT) is a national vaccine commercialization consortium that specializes in research and development of vaccines for infectious diseases. The institute develops vaccines for infectious disease, group A streptococcus vaccine, chlamydia vaccine, influ …
  • Nephros Inc (NEPH):企業の財務・戦略的SWOT分析
    Summary Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended …
  • Sabre Corporation:企業の戦略・SWOT・財務分析
    Sabre Corporation - Strategy, SWOT and Corporate Finance Report Summary Sabre Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shoprite Holdings Ltd:戦略・SWOT・企業財務分析
    Shoprite Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Shoprite Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Seafarms Group Limited (SFG):企業の財務・戦略的SWOT分析
    Seafarms Group Limited (SFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Regal Petroleum plc (RPT):企業の財務・戦略的SWOT分析
    Summary Regal Petroleum Plc (Regal), a subsidiary of Energees Investments Ltd, is an oil and gas company that conducts reviews on oil and gas projects. The company operates two gas and condensate fields such as Mekhediviska - Golotovschinska and Svyrydivske located in Dneipner-Donets basin in the no …
  • C&J Energy Services Inc (CJ):石油・ガス:M&Aディール及び事業提携情報
    Summary C&J Energy Services Inc (C&J) is a provider of onshore well construction, completion, support and other complementary oilfield services. The company offers vertically-integrated suite of services involved in the entire life cycle of the well, including hydraulic fracturing, cased-hole wireli …
  • LivePerson Inc (LPSN):企業の財務・戦略的SWOT分析
    LivePerson Inc (LPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆